ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

The Varmus Era: Controversy Continues

January 6, 1995

Reimbursement Policy By Philadelphia Blue Cross Further Explained

April 21, 1989

In Brief: Glantz, Waxman, Wigand honored For Work Opposing tobacco; CTRC Names Executives

February 16, 1996

Prevention Program Being Developed For Primary Providers

January 29, 1988

In Brief” McKenna New ACS President, Lemaistre President Elect; Michael Potter Wins Albert Lasker Award

November 23, 1984

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011